Literature DB >> 25865512

Patterns of disclosure and antiretroviral treatment adherence in a South African mining workplace programme and implications for HIV prevention.

Anil Bhagwanjee1, Kaymarlin Govender, Olagoke Akintola, Inge Petersen, Gavin George, Leigh Johnstone, Kerisha Naidoo.   

Abstract

Social and psychological barriers to the disclosure of one's seropositive HIV status to significant others and poor adherence to taking medications pose significant challenges to the scaling-up of access to antiretroviral treatment (ART) in the workplace. Such barriers are predictive of sub-optimal treatment outcomes and bedevil HIV-prevention interventions at a societal level. Against this background, this article explores the lived experiences of 19 HIV-positive male participants, between the ages of 33 and 57 years, who were enrolled in an ART programme managed at an occupational health clinic at a mining company in South Africa. The majority of these mineworkers had been aware of their HIV status for between 5 and 7 years. The study explored psychological and relational factors, as aspects of these participants lived experiences, which had a bearing on their adherence to their ART regimen and the disclosure choices that they made regarding their HIV status. In our sample, those participants who were adherent demonstrated higher levels of control and acceptance of their HIV infection and were more confident in their ability to manage their treatment, while the group who were non-adherent presented with lower levels of adherence motivation and self-efficacy, difficulties in maintaining a healthy lifestyle and significant challenges in maintaining control over their lives. While most of the men favoured disclosing their HIV status to their partners for the sake of treatment support, they were less sure about disclosing to family members and non-family members, respectively, because of their need to protect these persons and due to their fear of being stigmatised. It was evident that treatment adherence choices and behaviours were impacted by psychological and relational factors, including disclosure decisions. We conclude with a bivariate model for understanding the adherence behaviours that influenced different patterns of ART adherence among the sample, and offer recommendations for HIV-prevention and treatment interventions in a mining workplace.

Entities:  

Keywords:  HAART; HIV/AIDS; assessment methods; behaviour; psychological factors; self-efficacy; social support

Year:  2011        PMID: 25865512     DOI: 10.2989/16085906.2011.637737

Source DB:  PubMed          Journal:  Afr J AIDS Res        ISSN: 1608-5906            Impact factor:   1.300


  5 in total

1.  Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review.

Authors:  Tessa Heestermans; Joyce L Browne; Susan C Aitken; Sigrid C Vervoort; Kerstin Klipstein-Grobusch
Journal:  BMJ Glob Health       Date:  2016-12-30

Review 2.  Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa.

Authors:  Natasha Croome; Monisha Ahluwalia; Lyndsay D Hughes; Melanie Abas
Journal:  AIDS       Date:  2017-04-24       Impact factor: 4.177

3.  Development and Acceptability of a Tablet-Based App to Support Men to Link to HIV Care: Mixed Methods Approach.

Authors:  Maryam Shahmanesh; Ann Blandford; Thulile Mathenjwa; Oluwafemi Adeagbo; Thembelihle Zuma; Keabetswe Dikgale; Anya Zeitlin; Philippa Matthews; Janet Seeley; Sally Wyke; Frank Tanser
Journal:  JMIR Mhealth Uhealth       Date:  2020-11-24       Impact factor: 4.773

4.  Gendered constructions of the impact of HIV and AIDS in the context of the HIV-positive seroconcordant heterosexual relationship.

Authors:  Anil Bhagwanjee; Kaymarlin Govender; Candice Reardon; Leigh Johnstone; Gavin George; Sarah Gordon
Journal:  J Int AIDS Soc       Date:  2013-05-15       Impact factor: 5.396

5.  Age-targeted HIV treatment and primary prevention as a 'ring fence' to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South Africa.

Authors:  Anna Bershteyn; Daniel J Klein; Philip A Eckhoff
Journal:  Int Health       Date:  2016-03-23       Impact factor: 2.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.